Abstract
The Frog Embryo Teratogenesis Assay Xenopus (FETAX) test is a development toxicity screening test. Due to the small amount of compound needed and the capability to study organogenesis in a short period of time (96 h), FETAX test constitutes an efficient development toxicity alert test when performed early in drug safety development. The test is conducted on fertilized Xenopus laevis mid-blastula stage eggs over the organogenesis period. Compound teratogenic potential is determined after analysis of the mortality and malformation observations on larva. In parallel, FETAX test provides also information concerning embryotoxic effect based on larva length.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
ASTM. (1998) Standard guide for conducting the frog embryo teratogenesis assay – Xenopus. Designation E 1439-98. In Annual book of ASTM standards, Vol 11.5. American Society for Testing and Materials, Philadelphia, pp. 825–836.
Bantle, J.A., Finch R.A., Burton, D.T., Fort, D.J., Dawson, D.A., Linder, G., Rayburn, J.R., Hull, M., Kumsher-King, M., Gaudet-Hull, A.M., and Turley, S.D. (1996) FETAX interlaboratory validation study: Phase III – Part 1 testing. J. Appl. Toxicol. 16(6), 517–528.
Sipe, C.W., and Saha, M.S. (2007) The use of microarray technology in non mammalian vertebrate systems. In Microarrays: Volume II: Applications and Data Analysis. Methods in Molecular Biology. Vol 382 (Rampal, J.B., ed.), Humana, Totowa, NJ, pp. 1–16.
Vallée, M., Aiba, K., Piao, Y., Palin, M.F., Ko, M.S., and Sirard, M.A. (2008) Comparative analysis of oocyte transcript profiles reveals a high degree of conservation among species. Reproduction 135(4), 439–448.
Bantle, J.A., Dumont, J.N., Finch, R.A., Linder G., and Fort, D.J. (1998) Atlas of abnormalities, a guide for the performance of FETAX, 2nd ed. Oklahoma State University, Stillwater, OK.
Fort, D.J., Stover, E.L., Bantle, J.A., Rayburn, J.R., Hull, M.A., Finch, R.A., Burton, D.T., Turley, S.D., Dawson, D.A., Linder, G., Buchwalter, D., Dumont, J.N., Kumsher-King, M., and Gaudet-Hull, A.M. (1998) Phase III interlaboratory study of FETAX, Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay-Xenopus (FETAX). Drug Chem. Toxicol. 21(1), 1–14.
Bantle, J.A., Finch, R.A., Fort, D.J., Stover, E.L., Hull, M., Kumsher-King, M., and Gaudet-Hull, A.M. (1999) Phase III interlaboratory study of FETAX. Part 3. FETAX Validation using 12 compounds with and without an exogenous metabolic activation system. J. Appl. Toxicol. 19, 447–472.
Fort, D.J., Rogers, R.L., Stover, E.L., and Finch, R.A. (2001) Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixtures. Drug Chem. Toxicol. 24(2), 103–115.
Fort, D.J., Rogers, R.L., Paul, R.R., Stover, E.L., and Finch, R.A. (2001) Optimization of an exogenous metabolic activation system for FETAX. II. Preliminary evaluation. Drug Chem. Toxicol. 24(2), 117–127.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Mouche, I., Malesic, L., Gillardeaux, O. (2011). FETAX Assay for Evaluation of Developmental Toxicity. In: Gautier, JC. (eds) Drug Safety Evaluation. Methods in Molecular Biology, vol 691. Humana Press. https://doi.org/10.1007/978-1-60761-849-2_15
Download citation
DOI: https://doi.org/10.1007/978-1-60761-849-2_15
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-186-8
Online ISBN: 978-1-60761-849-2
eBook Packages: Springer Protocols